Nuclear magnetic relaxation dispersion of murine tissue for development of <i>T</i>₁ (<i>R</i>₁) dispersion contrast imaging

Abstract

This study quantified the spin-lattice relaxation rate (R₁ ) dispersion of murine tissues from 0.24 mT to 3 T. A combination of ex vivo and in vivo spin-lattice relaxation rate measurements were acquired for murine tissue. Selected brain, liver, kidney, muscle, and fat tissues were excised and R₁ dispersion profiles were acquired from 0.24 mT to 1.0 T at 37 °C, using a fast field-cycling MR (FFC-MR) relaxometer. In vivo R₁ dispersion profiles of mice were acquired from 1.26 T to 1.74 T at 37 °C, using FFC-MRI on a 1.5 T scanner outfitted with a field-cycling insert electromagnet to dynamically control B₀ prior to imaging. Images at five field strengths (1.26, 1.39, 1.5, 1.61, 1.74 T) were acquired using a field-cycling pulse sequence, where B₀ was modulated for varying relaxation durations prior to imaging. R₁ maps and R₁ dispersion (ΔR₁ /ΔB₀ ) were calculated at 1.5 T on a pixel-by-pixel basis. In addition, in vivo R₁ maps of mice were acquired at 3 T. At fields less than 1 T, a large R₁ magnetic field dependence was observed for tissues. ROI analysis of the tissues showed little relaxation dispersion for magnetic fields from 1.26 T to 3 T. Our tissue measurements show strong R₁ dispersion at field strengths less than 1 T and limited R₁ dispersion at field strengths greater than 1 T. These findings emphasize the inherent weak R₁ magnetic field dependence of healthy tissues at clinical field strengths. This characteristic of tissues can be exploited by a combination of FFC-MRI and T₁ contrast agents that exhibit strong relaxivity magnetic field dependences (inherent or by binding to a protein), thereby increasing the agents' specificity and sensitivity. This development can provide potential insights into protein-based biomarkers using FFC-MRI to assess early changes in tumour development, which are not easily measureable with conventional MRI.